#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13496	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2420	682.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1892	1892	T	887	T,G	884,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13496	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2420	682.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1626	1626	C	931	C,G,A	929,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22738	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4042	700.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1894	1894	A	955	A,G,C	951,2,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22738	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4042	700.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2528	2528	C	816	C	816	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22738	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4042	700.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2602	2602	A	709	A,T	707,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22738	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4042	700.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3154	3154	C	814	C	814	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1962	folP	855	855	100.0	folP.l15.c4.ctg.1	1960	124.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1159	1161	AGC	191;191;190	A;G;C,G	191;191;189,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4952	gyrA	2751	2751	100.0	gyrA.l6.c17.ctg.1	3969	155.6	1	SNP	p	S91F	1	.	.	271	273	TTC	920	922	TTC	181;184;184	T;T;C	181;184;184	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4952	gyrA	2751	2751	100.0	gyrA.l6.c17.ctg.1	3969	155.6	1	SNP	p	G95N	0	.	.	283	285	GGC	932	934	GGC	177;177;177	G;G;C	177;177;177	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4952	gyrA	2751	2751	100.0	gyrA.l6.c17.ctg.1	3969	155.6	1	SNP	p	D95G	1	.	.	283	285	GGC	932	934	GGC	177;177;177	G;G;C	177;177;177	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	1784	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1872	118.4	1	SNP	p	G45D	1	.	.	133	135	GAC	801	803	GAC	182;181;183	G;A;C	182;181;183	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	930	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1468	78.6	0	.	n	.	0	A197.	DEL	197	197	A	890	890	A	174	A	174	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4466	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3397	163.6	1	SNP	p	D86N	1	D86N	NONSYN	256	258	GAC	766	768	AAC	207;207;206	A;A;C	207;207;206	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4466	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3397	163.6	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1813	1815	GCA	195;199;201	G;C;A	195;199;201	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4466	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3397	163.6	1	SNP	p	S87W	0	.	.	259	261	AGT	769	771	AGT	206;206;205	A,G;G;T	204,2;206;205	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4466	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3397	163.6	1	SNP	p	S87R	0	.	.	259	261	AGT	769	771	AGT	206;206;205	A,G;G;T	204,2;206;205	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4466	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3397	163.6	1	SNP	p	S87I	0	.	.	259	261	AGT	769	771	AGT	206;206;205	A,G;G;T	204,2;206;205	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4466	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3397	163.6	1	SNP	p	S88P	0	.	.	262	264	TCC	772	774	TCC	204;205;207	T;C,T,G;CG,C	204;203,1,1;202,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3978	parE	1986	1986	99.9	parE.l15.c4.ctg.1	3348	148.0	0	.	p	.	0	V89A	NONSYN	265	267	GTC	942	944	GCC	167;168;167	G,A;C;C	166,1;168;167	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3978	parE	1986	1986	99.9	parE.l15.c4.ctg.1	3348	148.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1905	1907	GGC	221;218;216	G;G,C;C	221;217,1;216	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	3906	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2931	166.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1465	1467	GCA	227;228;227	G,A;C;A	226,1;228;227	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3906	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2931	166.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1468	1470	ATC	227;227;226	A,T;T;C	226,1;227;226	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3906	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2931	166.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1480	1482	GTG	233;234;236	G;T;G,T	233;234;235,1	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3906	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2931	166.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1480	1482	GTG	233;234;236	G;T;G,T	233;234;235,1	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3906	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2931	166.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1984	1986	ACC	224;225;225	A;C;C	224;225;225	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3906	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2931	166.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2038	2040	GCG	221;222;226	G,T;C;G,T	220,1;222;225,1	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3906	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2931	166.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2038	2040	GCG	221;222;226	G,T;C;G,T	220,1;222;225,1	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3906	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2931	166.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2161	2163	GGC	210;210;210	G;G;C	210;210;210	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3906	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2931	166.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2170	2172	GGC	208;207;209	G;G;C	208;207;209	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3906	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2931	166.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2188	2190	CCG	203;206;202	C,G;C,T;G,C	201,2;205,1;201,1	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5366	ponA	2397	2397	99.87	ponA.l15.c4.ctg.1	3640	183.5	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1795	1797	ACG	252;253;250	A,G;C,A;G	251,1;252,1;250	.	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5366	ponA	2397	2397	99.87	ponA.l15.c4.ctg.1	3640	183.5	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1933	1935	CTG	212;214;211	C;T,C;G	211;212,1;211	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2216	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2408	114.5	0	.	p	.	0	S22G	NONSYN	64	66	AGC	704	706	GGC	170;169;170	G,A;G;C	169,1;169;170	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2216	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2408	114.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	886	886	C	158	C,T	157,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	276	porB1a	984	156	93.59	porB1a.l15.c17.ctg.3	156	56.9	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	35;39;42	T;T;A	35;39;42	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	276	porB1a	984	156	93.59	porB1a.l15.c17.ctg.3	156	56.9	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	71;71;71	C;A;T	71;71;71	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	276	porB1a	984	156	93.59	porB1a.l15.c17.ctg.3	156	56.9	0	.	p	.	0	D274G	NONSYN	820	822	GAT	62	64	GGT	71;71;71	G;G;T	71;71;71	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	276	porB1a	984	156	93.59	porB1a.l15.c17.ctg.3	156	56.9	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	71;71;71	T;A;C	71;71;71	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	98.1	porB1b.l15.c17.ctg.1	2042	153.8	0	.	p	.	0	T26A	NONSYN	76	78	ACC	656	658	GCC	195;196;195	G,C;C,A;C	194,1;195,1;195	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	98.1	porB1b.l15.c17.ctg.1	2042	153.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	692	694	GAA	195;194;195	G,C;A,C;A	193,2;193,1;195	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	98.1	porB1b.l15.c17.ctg.1	2042	153.8	0	.	p	.	0	K41D	NONSYN	121	123	AAA	701	703	GAC	197;199;199	G,C;A;C	196,1;199;199	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	98.1	porB1b.l15.c17.ctg.1	2042	153.8	0	.	p	.	0	N134D	NONSYN	400	402	AAT	980	982	GAT	221;222;221	G,A;A;T,C	219,1;222;219,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	98.1	porB1b.l15.c17.ctg.1	2042	153.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1103	1105	TCA	220;218;218	T;C;A,C	220;218;217,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	98.1	porB1b.l15.c17.ctg.1	2042	153.8	0	.	p	.	0	D212N	NONSYN	634	636	GAT	1214	1216	AAT	220;220;218	A;A;T,C,A	220;220;216,1,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	98.1	porB1b.l15.c17.ctg.1	2042	153.8	0	.	p	.	0	A218I	NONSYN	652	654	GCC	1232	1234	ATC	212;214;212	A;T;C	212;214;212	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	98.1	porB1b.l15.c17.ctg.1	2042	153.8	0	.	p	.	0	F222L	NONSYN	664	666	TTT	1244	1246	CTT	215;216;215	C,T;T,G;T	213,1;215,1;214	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	98.1	porB1b.l15.c17.ctg.1	2042	153.8	0	.	p	.	0	G255_T256insR	INS	763	763	G	1343	1343	G	209	G	209	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	98.1	porB1b.l15.c17.ctg.1	2042	153.8	0	.	p	.	0	N260S	NONSYN	778	780	AAT	1361	1363	AGT	195;193;196	A,C;G,T;T	194,1;192,1;196	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	98.1	porB1b.l15.c17.ctg.1	2042	153.8	0	.	p	.	0	S295G	NONSYN	883	885	AGT	1466	1468	GGT	209;210;210	G,T;G;T	208,1;210;210	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	98.1	porB1b.l15.c17.ctg.1	2042	153.8	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1565	1567	GCA	213;214;210	G,T;C,A;A	211,2;213,1;210	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	98.1	porB1b.l15.c17.ctg.1	2042	153.8	1	SNP	p	G120K	1	.	.	358	360	AAG	938	940	AAG	215;215;211	A,T;A,G;G,C,A	213,2;214,1;208,1,2	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	98.1	porB1b.l15.c17.ctg.1	2042	153.8	1	SNP	p	D121N	0	.	.	361	363	GAC	941	943	GAC	210;213;214	G,C;A;C,A	209,1;213;213,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	98.1	porB1b.l15.c17.ctg.1	2042	153.8	1	SNP	p	A121D	1	.	.	361	363	GAC	941	943	GAC	210;213;214	G,C;A;C,A	209,1;213;213,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9046	rpoB	4179	4179	99.95	rpoB.l6.c4.ctg.1	5433	207.4	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2292	2294	AAT	228;230;230	A,G,C;A;T,G	225,1,1;229;228,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1316	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1663	98.8	1	SNP	p	V57M	1	.	.	169	171	ATG	844	846	ATG	222;222;221	A,T;T;G	221,1;222;221	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
